Why Rare Disease Requires More Than Innovation Alone
As part of DHC’s Rare Disease Month coverage, David Ormesher joined Disruptive Dose to explore a critical idea: success in pharma isn’t driven by innovation alone—it requires a system built to support it.
The conversation focuses on how organizations can better align people, processes, and technology to deliver meaningful outcomes.
